European Respiratory Society
@europeanrespsoc.bsky.social
A non-profit organisation dedicated to sharing scientific knowledge, fighting lung disease and promoting lung health. ERS has more than 35,000 members worldwide. ersnet.org
Biallelic SERPINA1 Q0 variants lead to early-onset emphysema even in nonsmokers, mandating early-life preventive and therapeutic measures. ZZ patients' lungs on shut-off transcription strategies equating them to “null” variants should also be protected. https://bit.ly/4mIlRL9
November 27, 2025 at 4:05 PM
Biallelic SERPINA1 Q0 variants lead to early-onset emphysema even in nonsmokers, mandating early-life preventive and therapeutic measures. ZZ patients' lungs on shut-off transcription strategies equating them to “null” variants should also be protected. https://bit.ly/4mIlRL9
ERJ Open Research: Climate change and global warming may increase NTM infection incidence. In Italy, subjects who live in hotter, less ventilated climates with reduced precipitation and higher degree of urbanisation are at higher risk of NTM infection. https://bit.ly/3YBufS3
November 26, 2025 at 4:12 PM
ERJ Open Research: Climate change and global warming may increase NTM infection incidence. In Italy, subjects who live in hotter, less ventilated climates with reduced precipitation and higher degree of urbanisation are at higher risk of NTM infection. https://bit.ly/3YBufS3
ERJ Open Research: Airway abnormalities and treatable traits https://bit.ly/4ox58L4
November 25, 2025 at 6:13 PM
ERJ Open Research: Airway abnormalities and treatable traits https://bit.ly/4ox58L4
This study revealed 39% prevalence of low adherence (LA) to diuretics over 12 months. It suggests that LA to diuretics was associated with worse outcomes. Potential risk factors for LA include younger age, active employment and high perceived PH knowledge. https://bit.ly/4li8IYe
November 25, 2025 at 3:49 PM
This study revealed 39% prevalence of low adherence (LA) to diuretics over 12 months. It suggests that LA to diuretics was associated with worse outcomes. Potential risk factors for LA include younger age, active employment and high perceived PH knowledge. https://bit.ly/4li8IYe
The #Respiratory Failure and Mechanical Ventilation Conference 2026 offers cutting-edge scientific sessions and interactive educational content.
📆 12–14 February, 2026
🌍 Rotterdam, Netherlands
💻 In-person and online
Register your place: bit.ly/4iAt5xa
📆 12–14 February, 2026
🌍 Rotterdam, Netherlands
💻 In-person and online
Register your place: bit.ly/4iAt5xa
November 25, 2025 at 8:46 AM
The #Respiratory Failure and Mechanical Ventilation Conference 2026 offers cutting-edge scientific sessions and interactive educational content.
📆 12–14 February, 2026
🌍 Rotterdam, Netherlands
💻 In-person and online
Register your place: bit.ly/4iAt5xa
📆 12–14 February, 2026
🌍 Rotterdam, Netherlands
💻 In-person and online
Register your place: bit.ly/4iAt5xa
ERJ Open Research: Cardiovascular disease significantly affects non-cystic fibrosis bronchiectasis, increasing mortality and exacerbation risk. This study, using TBARC data, emphasises the need for integrated cardiovascular care to improve outcomes. https://bit.ly/3GI7rd4
November 24, 2025 at 5:12 PM
ERJ Open Research: Cardiovascular disease significantly affects non-cystic fibrosis bronchiectasis, increasing mortality and exacerbation risk. This study, using TBARC data, emphasises the need for integrated cardiovascular care to improve outcomes. https://bit.ly/3GI7rd4
Breathe: Psychosis is a potential side-effect of isoniazid therapy that clinicians involved in the care of patients with tuberculosis should be aware of. https://bit.ly/4n2gXrX
November 24, 2025 at 3:50 PM
Breathe: Psychosis is a potential side-effect of isoniazid therapy that clinicians involved in the care of patients with tuberculosis should be aware of. https://bit.ly/4n2gXrX
📹 Guidelines in Focus: Prof. Saskia Bos interviews Dr Georgia Hardavella about the newly published ERS and European Society of Thoracic Surgeons
clinical practice guideline on fitness for curative intent treatment of lung cancer.
Watch now: https://bit.ly/49P6kVx
#LungCancerAwarenessMonth
clinical practice guideline on fitness for curative intent treatment of lung cancer.
Watch now: https://bit.ly/49P6kVx
#LungCancerAwarenessMonth
November 24, 2025 at 12:10 PM
📹 Guidelines in Focus: Prof. Saskia Bos interviews Dr Georgia Hardavella about the newly published ERS and European Society of Thoracic Surgeons
clinical practice guideline on fitness for curative intent treatment of lung cancer.
Watch now: https://bit.ly/49P6kVx
#LungCancerAwarenessMonth
clinical practice guideline on fitness for curative intent treatment of lung cancer.
Watch now: https://bit.ly/49P6kVx
#LungCancerAwarenessMonth
Innovations in technology will revolutionise lung function assessment through three approaches: newer techniques (e.g. oscillometry), data acquisition through digital devices outside the clinic and data analysis through artificial intelligence tools. https://bit.ly/46qRf9C
November 23, 2025 at 5:38 PM
Innovations in technology will revolutionise lung function assessment through three approaches: newer techniques (e.g. oscillometry), data acquisition through digital devices outside the clinic and data analysis through artificial intelligence tools. https://bit.ly/46qRf9C
Reducing the use of oral corticosteroids (OCS) in severe asthma is now a key clinical objective; health economic modelling of OCS-sparing strategies indicates that early action would have a tangible, positive impact on the cost of OCS-related comorbidities https://bit.ly/3YBvfp9
November 23, 2025 at 2:07 PM
Reducing the use of oral corticosteroids (OCS) in severe asthma is now a key clinical objective; health economic modelling of OCS-sparing strategies indicates that early action would have a tangible, positive impact on the cost of OCS-related comorbidities https://bit.ly/3YBvfp9
This article presents the pathophysiological mechanisms by which patients with pleural effusion experience dyspnoea and the mechanism by which these patients may clinically benefit from thoracentesis, regardless of the size of the pleural effusion. https://bit.ly/486GQC7
November 22, 2025 at 4:06 PM
This article presents the pathophysiological mechanisms by which patients with pleural effusion experience dyspnoea and the mechanism by which these patients may clinically benefit from thoracentesis, regardless of the size of the pleural effusion. https://bit.ly/486GQC7
ERJ Open Research: Increasing shift work frequency is more strongly related to asthma in females than in males https://bit.ly/4jfPml8
November 22, 2025 at 1:37 PM
ERJ Open Research: Increasing shift work frequency is more strongly related to asthma in females than in males https://bit.ly/4jfPml8
Rigid bronchoscopy permits direct visualisation and intervention within the central airways, enabling complex therapeutic procedures, e.g. foreign body removal, tumour debulking, stent deployment, and in massive haemoptysis; general anaesthesia is mandated https://bit.ly/3KLVepN
November 21, 2025 at 4:11 PM
Rigid bronchoscopy permits direct visualisation and intervention within the central airways, enabling complex therapeutic procedures, e.g. foreign body removal, tumour debulking, stent deployment, and in massive haemoptysis; general anaesthesia is mandated https://bit.ly/3KLVepN
ERJOR: Airway NETs are increased in obese people with asthma, while NETs are also associated with BMI. Airway eDNA is associated with lower lung function and asthma control. NETs are likely source of eDNA as DNA–elastase complexes correlate with eDNA. https://bit.ly/43s0R3A
November 21, 2025 at 2:58 PM
ERJOR: Airway NETs are increased in obese people with asthma, while NETs are also associated with BMI. Airway eDNA is associated with lower lung function and asthma control. NETs are likely source of eDNA as DNA–elastase complexes correlate with eDNA. https://bit.ly/43s0R3A
At #COP11, ERS is coordinating with partners and observing negotiations to bring strong respiratory-health evidence into discussions, from environmental protections to safeguarding future generations 🌍🚭
Learn more about ERS #tobaccocontrol activities: https://bit.ly/3AvuHIV
Learn more about ERS #tobaccocontrol activities: https://bit.ly/3AvuHIV
November 20, 2025 at 6:30 PM
At #COP11, ERS is coordinating with partners and observing negotiations to bring strong respiratory-health evidence into discussions, from environmental protections to safeguarding future generations 🌍🚭
Learn more about ERS #tobaccocontrol activities: https://bit.ly/3AvuHIV
Learn more about ERS #tobaccocontrol activities: https://bit.ly/3AvuHIV
Breathe: Aspergillosis is often overlooked, but recognising it early in patients with chronic or recurrent lung infections can be life-changing. Lisa's experience shows why clinicians must consider aspergillosis. https://bit.ly/3WPqas3
November 20, 2025 at 5:14 PM
Breathe: Aspergillosis is often overlooked, but recognising it early in patients with chronic or recurrent lung infections can be life-changing. Lisa's experience shows why clinicians must consider aspergillosis. https://bit.ly/3WPqas3
ERJ Open Research: Physiological variability measures significantly differ between stable and exacerbating groups of COPD patients. This can be used to build exacerbation detection algorithms in the future, leading to improved patient outcomes. https://bit.ly/4d2YMOC
November 20, 2025 at 4:10 PM
ERJ Open Research: Physiological variability measures significantly differ between stable and exacerbating groups of COPD patients. This can be used to build exacerbation detection algorithms in the future, leading to improved patient outcomes. https://bit.ly/4d2YMOC
The latest Interactive Education, ‘Early diagnosis of ILD’, uses real-world clinical scenarios to bridge gaps in knowledge and enhance decision-making around early ILD and interstitial lung abnormalities (ILA), familial risk, genetic testing, and more.
Watch now: https://bit.ly/443ekP3
Watch now: https://bit.ly/443ekP3
November 20, 2025 at 1:48 PM
The latest Interactive Education, ‘Early diagnosis of ILD’, uses real-world clinical scenarios to bridge gaps in knowledge and enhance decision-making around early ILD and interstitial lung abnormalities (ILA), familial risk, genetic testing, and more.
Watch now: https://bit.ly/443ekP3
Watch now: https://bit.ly/443ekP3
Administrative health data are often used to assess guideline-concordance in COPD medication use, but definitions of guideline-concordance vary. This study reviewed these definitions, highlighting the utility of administrative data in analysing COPD care. https://bit.ly/4iz7nKa
November 19, 2025 at 5:35 PM
Administrative health data are often used to assess guideline-concordance in COPD medication use, but definitions of guideline-concordance vary. This study reviewed these definitions, highlighting the utility of administrative data in analysing COPD care. https://bit.ly/4iz7nKa
European Respiratory Journal: This multidisciplinary panel of lung cancer experts from different specialties has generated practical and up-to-date recommendations to assess patients’ fitness for curative intent treatment for lung cancer https://bit.ly/4m57e3s
November 19, 2025 at 4:10 PM
European Respiratory Journal: This multidisciplinary panel of lung cancer experts from different specialties has generated practical and up-to-date recommendations to assess patients’ fitness for curative intent treatment for lung cancer https://bit.ly/4m57e3s
📄 ERS and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer has now been published in the European Respiratory Journal.
Access the guideline and all associated content via the ERS Respiratory Channel: https://bit.ly/4qW4GI5
Access the guideline and all associated content via the ERS Respiratory Channel: https://bit.ly/4qW4GI5
November 19, 2025 at 11:26 AM
📄 ERS and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer has now been published in the European Respiratory Journal.
Access the guideline and all associated content via the ERS Respiratory Channel: https://bit.ly/4qW4GI5
Access the guideline and all associated content via the ERS Respiratory Channel: https://bit.ly/4qW4GI5
ERR: Several countries have recently updated their recommendations by including PCV20 in vaccination strategies for older adults and individuals at high risk for pneumococcal disease. PCV20 is safe, effective and believed to reduce healthcare costs. https://bit.ly/425aeVL
November 18, 2025 at 5:51 PM
ERR: Several countries have recently updated their recommendations by including PCV20 in vaccination strategies for older adults and individuals at high risk for pneumococcal disease. PCV20 is safe, effective and believed to reduce healthcare costs. https://bit.ly/425aeVL
ERJ Open Res: Novel electrochemical NO measurement during laryngeal mask ventilation showed promising repeatability and precision in screening for PCD in children <5 years. This may help diagnose PCD in young patients and simplify differential diagnostics. https://bit.ly/43kifHf
November 18, 2025 at 4:13 PM
ERJ Open Res: Novel electrochemical NO measurement during laryngeal mask ventilation showed promising repeatability and precision in screening for PCD in children <5 years. This may help diagnose PCD in young patients and simplify differential diagnostics. https://bit.ly/43kifHf
More than 1,400 delegates from 162 Parties have gathered in Geneva this week for #COP11, the world’s main decision-making forum on tobacco control under the WHO Framework Convention on Tobacco Control.
Read the ERS statement to COP11: https://bit.ly/49IHozh
#lunghealth
Read the ERS statement to COP11: https://bit.ly/49IHozh
#lunghealth
November 18, 2025 at 10:16 AM
More than 1,400 delegates from 162 Parties have gathered in Geneva this week for #COP11, the world’s main decision-making forum on tobacco control under the WHO Framework Convention on Tobacco Control.
Read the ERS statement to COP11: https://bit.ly/49IHozh
#lunghealth
Read the ERS statement to COP11: https://bit.ly/49IHozh
#lunghealth
European Respiratory Review: Several gene mutations have been reported to cause early-onset emphysema with known Mendelian traits. Next-generation sequencing offers a promising method to understand early-onset emphysema and COPD pathogenesis. https://bit.ly/4695zEM
November 17, 2025 at 5:13 PM
European Respiratory Review: Several gene mutations have been reported to cause early-onset emphysema with known Mendelian traits. Next-generation sequencing offers a promising method to understand early-onset emphysema and COPD pathogenesis. https://bit.ly/4695zEM